Daisuke Nishizaki

6PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|May 05, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|Jan 08, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.

Jason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita

|Aug 06, 2025
Pan-Cancer Landscape of B- and T-Lymphocyte Attenuator: Implications for Potential Immunotherapy Combinations.

Daisuke Nishizaki, Sharon Choi, Chinmayi Pandya

|Oct 16, 2024
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.

Jonathan Weitz, Daisuke Nishizaki, Joy Liau

|May 10, 2023
What can surgeons do to prevent job leave soon after cancer diagnosis? A brief report on colorectal cancer survivors in Japan.

Daisuke Nishizaki, Yusuke Fujita, Takashi Sakamoto

Pageof 1

Frequent Collaborators

4 joint publications

Razelle Kurzrock

4 joint publications

Shumei Kato

3 joint publications

Mina Nikanjam

3 joint publications

Jason K Sicklick